Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis

Introduction The high morbidity and mortality associated with invasive fungal infections (IFIs) provide the rationale for antifungal prophylaxis in immuno-compromised pediatric patients undergoing hematopoietic stem cell transplantation (HSCT). Caspofungin and micafungin are antifungal agents of int...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Advances in therapy 2017-05, Vol.34 (5), p.1184-1199
Hauptverfasser:	Maximova, Natalia, Schillani, Giulia, Simeone, Roberto, Maestro, Alessandra, Zanon, Davide
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antifungal Agents - therapeutic use Cardiology Child Child, Preschool Cohort Studies Echinocandins - therapeutic use Endocrinology Female Health technology assessment Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods Humans Infant Infant, Newborn Internal Medicine Lipopeptides - therapeutic use Male Medicine Medicine & Public Health Mycoses - drug therapy Mycoses - etiology Neutropenia - chemically induced Oncology Original Research Pharmacology/Toxicology Retrospective Studies Rheumatology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!